Further studies on patients with moderate-to-severe decreased cardiac function to investigate the synergy of anti-TNF and heart failure are needed; likewise, other patients with autoimmune diseases, including CD, who are receiving ADA, should be considered. Here, ADA is linked to autoimmune disease.